Yang, H-C <br/><br/>
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.  [electronic resource] 

 -  Kidney international  May 2006 
 - 1756-64 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1038/sj.ki.5000336  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiopoietin-Like Protein 4<br/>Angiopoietins<br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Blood Pressure--drug effects<br/>Blood Proteins--metabolism<br/>Body Weight--drug effects<br/>Drug Evaluation, Preclinical<br/>Glomerular Filtration Rate--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Kidney--pathology<br/>Male<br/>PPAR gamma--agonists<br/>Pioglitazone<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Podocytes--pathology<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Protective Agents--therapeutic use<br/>Puromycin Aminonucleoside--administration & dosage<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sclerosis--drug therapy<br/>Thiazolidinediones--pharmacology<br/>Vascular Endothelial Growth Factor A--genetics